|
Originally published In Press as doi:10.1074/jbc.M210652200 on May 13, 2003
J. Biol. Chem., Vol. 278, Issue 30, 28274-28283, July 25, 2003
Oligomerization of Dopamine Transporters Visualized in Living Cells by Fluorescence Resonance Energy Transfer Microscopy*
Tatiana Sorkina,
Suzanne Doolen,
Emilia Galperin,
Nancy R. Zahniser and
Alexander Sorkin
From the
Department of Pharmacology and Neuroscience Program, University of
Colorado Health Sciences Center, Denver, Colorado 80262
To examine the oligomeric state and trafficking of the dopamine transporter
(DAT) in different compartments of living cells, human DAT was fused to yellow
(YFP) or cyan fluorescent protein (CFP). YFP-DAT and CFP-DAT were transiently
and stably expressed in porcine aortic endothelial (PAE) cells, human
embryonic kidney (HEK) 293 cells, and an immortalized dopaminergic cell line
1RB3AN27. Fluorescence microscopic imaging of cells
co-expressing YFP-DAT and CFP-DAT revealed fluorescence resonance energy
transfer (FRET) between CFP and YFP, which is consistent with an
intermolecular interaction of DAT fusion proteins. FRET signals were detected
between CFP- and YFP-DAT located at the plasma membrane and in intracellular
membrane compartments. Phorbol esters or amphetamine induced the endocytosis
of YFP/CFP-DAT to early and recycling endosomes, identified by Rab5, Rab11,
Hrs and EEA.1 proteins. Interestingly, however, DAT was mainly excluded from
Rab5- and Hrs-containing microdomains within the endosomes. The strongest FRET
signals were measured in endosomes, indicative of efficient oligomerization of
internalized DAT. The intermolecular DAT interactions were confirmed by
co-immunoprecipitation. A DAT mutant that was retained in the endoplasmic
reticulum (ER) after biosynthesis was used to show that DAT is oligomeric in
the ER. Moreover, co-expression of an ER-retained DAT mutant and wild-type DAT
resulted in the retention of wild-type DAT in the ER. These data suggest that
DAT oligomers are formed in the ER and then are constitutively maintained both
at the cell surface and during trafficking between the plasma membrane and
endosomes.
Received for publication, October 18, 2002
, and in revised form, May 5, 2003.
* This work was supported by Grants DA14204 (to A. S. and N. R. Z.) and
DA1505 from National Institute on Drug Abuse (to N. R. Z.). The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology, University
of Colorado Health Science Center, 4200 E. Ninth Ave., Denver, CO 80262. Tel.:
303-315-7252; Fax: 303-315-7097; E-mail:
alexander.sorkin{at}uchsc.edu./.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Sorkina, T. L. Richards, A. Rao, N. R. Zahniser, and A. Sorkin
Negative Regulation of Dopamine Transporter Endocytosis by Membrane-Proximal N-Terminal Residues
J. Neurosci.,
February 4, 2009;
29(5):
1361 - 1374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bartholomaus, L. Milan-Lobo, A. Nicke, S. Dutertre, H. Hastrup, A. Jha, U. Gether, H. H. Sitte, H. Betz, and V. Eulenburg
Glycine Transporter Dimers: EVIDENCE FOR OCCURRENCE IN THE PLASMA MEMBRANE
J. Biol. Chem.,
April 18, 2008;
283(16):
10978 - 10991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. James, S. S. White, R. W. Clarke, A. M. Johansen, P. D. Dunne, D. L. Sleep, W. J. Fitzgerald, S. J. Davis, and D. Klenerman
Single-molecule level analysis of the subunit composition of the T cell receptor on live T cells
PNAS,
November 6, 2007;
104(45):
17662 - 17667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miranda and A. Sorkin
Regulation of Receptors and Transporters by Ubiquitination: New Insights into Surprisingly Similar Mechanisms
Mol. Interv.,
June 1, 2007;
7(3):
157 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bossi, A. Soragna, A. Miszner, S. Giovannardi, V. Frangione, and A. Peres
Oligomeric structure of the neutral amino acid transporters KAAT1 and CAATCH1
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1379 - C1387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Farhan, V. Reiterer, V. M. Korkhov, J. A. Schmid, M. Freissmuth, and H. H. Sitte
Concentrative Export from the Endoplasmic Reticulum of the {gamma}-Aminobutyric Acid Transporter 1 Requires Binding to SEC24D
J. Biol. Chem.,
March 9, 2007;
282(10):
7679 - 7689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders
Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism
Mol. Pharmacol.,
March 1, 2007;
71(3):
835 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miranda, K. R. Dionne, T. Sorkina, and A. Sorkin
Three Ubiquitin Conjugation Sites in the Amino Terminus of the Dopamine Transporter Mediate Protein Kinase C-dependent Endocytosis of the Transporter
Mol. Biol. Cell,
January 1, 2007;
18(1):
313 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fernandez, M. Jimenez-Vidal, M. Calvo, A. Zorzano, F. Tebar, M. Palacin, and J. Chillaron
The Structural and Functional Units of Heteromeric Amino Acid Transporters: THE HEAVY SUBUNIT rBAT DICTATES OLIGOMERIZATION OF THE HETEROMERIC AMINO ACID TRANSPORTERS
J. Biol. Chem.,
September 8, 2006;
281(36):
26552 - 26561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sorkina, M. Miranda, K. R. Dionne, B. R. Hoover, N. R. Zahniser, and A. Sorkin
RNA Interference Screen Reveals an Essential Role of Nedd4-2 in Dopamine Transporter Ubiquitination and Endocytosis
J. Neurosci.,
August 2, 2006;
26(31):
8195 - 8205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Korkhov, M. Holy, M. Freissmuth, and H. H. Sitte
The Conserved Glutamate (Glu136) in Transmembrane Domain 2 of the Serotonin Transporter Is Required for the Conformational Switch in the Transport Cycle
J. Biol. Chem.,
May 12, 2006;
281(19):
13439 - 13448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Blazek, M. Barboric, J. Kohoutek, I. Oven, and B. M. Peterlin
Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb
Nucleic Acids Res.,
December 23, 2005;
33(22):
7000 - 7010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miranda, C. C. Wu, T. Sorkina, D. R. Korstjens, and A. Sorkin
Enhanced Ubiquitylation and Accelerated Degradation of the Dopamine Transporter Mediated by Protein Kinase C
J. Biol. Chem.,
October 21, 2005;
280(42):
35617 - 35624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seidel, E. A. Singer, H. Just, H. Farhan, P. Scholze, O. Kudlacek, M. Holy, K. Koppatz, P. Krivanek, M. Freissmuth, et al.
Amphetamines Take Two to Tango: an Oligomer-Based Counter-Transport Model of Neurotransmitter Transport Explores the Amphetamine Action
Mol. Pharmacol.,
January 1, 2005;
67(1):
140 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jiang, Q. Jiang, and J. Feng
Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter
J. Biol. Chem.,
December 24, 2004;
279(52):
54380 - 54386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dong, W. H. Tepp, E. A. Johnson, and E. R. Chapman
Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells
PNAS,
October 12, 2004;
101(41):
14701 - 14706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bjerggaard, J. U. Fog, H. Hastrup, K. Madsen, C. J. Loland, J. A. Javitch, and U. Gether
Surface Targeting of the Dopamine Transporter Involves Discrete Epitopes in the Distal C Terminus But Does Not Require Canonical PDZ Domain Interactions
J. Neurosci.,
August 4, 2004;
24(31):
7024 - 7036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miranda, T. Sorkina, T. N. Grammatopoulos, W. M. Zawada, and A. Sorkin
Multiple Molecular Determinants in the Carboxyl Terminus Regulate Dopamine Transporter Export from Endoplasmic Reticulum
J. Biol. Chem.,
July 16, 2004;
279(29):
30760 - 30770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-B. Li, N. Chen, S. Ramamoorthy, L. Chi, X.-N. Cui, L. C. Wang, and M. E. A. Reith
The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine Transporter
J. Biol. Chem.,
May 14, 2004;
279(20):
21012 - 21020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Baucum II, K. S. Rau, E. L. Riddle, G. R. Hanson, and A. E. Fleckenstein
Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism
J. Neurosci.,
March 31, 2004;
24(13):
3436 - 3443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Kahlig, J. A. Javitch, and A. Galli
Amphetamine Regulation of Dopamine Transport: COMBINED MEASUREMENTS OF TRANSPORTER CURRENTS AND TRANSPORTER IMAGING SUPPORT THE ENDOCYTOSIS OF AN ACTIVE CARRIER
J. Biol. Chem.,
March 5, 2004;
279(10):
8966 - 8975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Just, H. H. Sitte, J. A. Schmid, M. Freissmuth, and O. Kudlacek
Identification of an Additional Interaction Domain in Transmembrane Domains 11 and 12 That Supports Oligomer Formation in the Human Serotonin Transporter
J. Biol. Chem.,
February 20, 2004;
279(8):
6650 - 6657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Sitte, H. Farhan, and J. A. Javitch
Sodium-Dependent Neurotransmitter TRANSPORTERS: OLIGOMERIZATION as a Determinant of Transporter Function and Trafficking
Mol. Interv.,
February 1, 2004;
4(1):
38 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hastrup, N. Sen, and J. A. Javitch
The Human Dopamine Transporter Forms a Tetramer in the Plasma Membrane: CROSS-LINKING OF A CYSTEINE IN THE FOURTH TRANSMEMBRANE SEGMENT IS SENSITIVE TO COCAINE ANALOGS
J. Biol. Chem.,
November 14, 2003;
278(46):
45045 - 45048.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|